Prof Hasan Tahir is currently involved in the cutting edge research of new biological therapies for Rheumatoid arthritis, Psoriatic arthritis and Ankylosing Spondylitis as well as COVID-19.
I am a chief / principal investigator for numerous clinical trials looking at new therapies for patients with inflammatory arthritis and COVID-19
I am very passionate about clinical research and am committed to continuing my involvement, despite a busy a clinical job, with the aim of providing patients the best opportunity to be part of research into musculoskeletal conditions and enhance the understanding of musculoskeletal disease.
My research interests are in Translational Research focussing on Immunotherapies / Biologics, Inflammatory Arthritis, Early AS and Tendinopathies.
I have presented outcomes of a number of research studies at a national and international level.
My drive to encourage research in our unit has resulted in research becoming a standard treatment option for all my patients.
